| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
SHL Telemedicine Ltd (SW: SHLTN)
SHLTN Technical Analysis
5
| As on 23rd Dec 2024 SHLTN STOCK Price closed @ 2.60 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 7.04 & Strong Sell for SHORT-TERM with Stoploss of 8.42 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SHLTNSTOCK Price
| Open | 2.42 | Change | Price | % |
| High | 2.63 | 1 Day | -0.05 | -1.89 |
| Low | 2.42 | 1 Week | 0.17 | 7.00 |
| Close | 2.60 | 1 Month | 0.10 | 4.00 |
| Volume | 4277 | 1 Year | -6.90 | -72.63 |
| 52 Week High 10.40 | 52 Week Low 2.29 | ||||
SW Switzerland Most Active Stocks
| CSGN | 0.82 | 0.00% |
| CSGN | 0.82 | 0.00% |
| UBSG | 27.07 | 1.35% |
| UBSG | 27.07 | 1.35% |
| IDIA | 0.73 | 15.87% |
| NESN | 74.08 | 0.14% |
| NESN | 74.08 | 0.14% |
| NOVN | 87.68 | 1.11% |
| NOVN | 87.68 | 1.11% |
| PRFN | 0.03 | 50.00% |
SW Switzerland Top Gainers Stocks
SW Switzerland Top Losers Stocks
| SHLTN Daily Charts |
SHLTN Intraday Charts |
Whats New @ Bazaartrend |
SHLTN Free Analysis |
|
|
SHLTN Important Levels Intraday
| RESISTANCE | 3.00 |
| RESISTANCE | 2.87 |
| RESISTANCE | 2.79 |
| RESISTANCE | 2.71 |
| SUPPORT | 2.49 |
| SUPPORT | 2.41 |
| SUPPORT | 2.33 |
| SUPPORT | 2.20 |
SHLTN Forecast December 2024
| 4th UP Forecast | 8 |
| 3rd UP Forecast | 6.27 |
| 2nd UP Forecast | 5.2 |
| 1st UP Forecast | 4.13 |
| 1st DOWN Forecast | 1.07 |
| 2nd DOWN Forecast | 0 |
| 3rd DOWN Forecast | -1.07 |
| 4th DOWN Forecast | -2.8 |
SHLTN Weekly Forecast
| 4th UP Forecast | 4.91 |
| 3rd UP Forecast | 4.17 |
| 2nd UP Forecast | 3.71 |
| 1st UP Forecast | 3.25 |
| 1st DOWN Forecast | 1.95 |
| 2nd DOWN Forecast | 1.49 |
| 3rd DOWN Forecast | 1.03 |
| 4th DOWN Forecast | 0.29 |
SHLTN Forecast2024
| 4th UP Forecast | 18.4 |
| 3rd UP Forecast | 13.33 |
| 2nd UP Forecast | 10.2 |
| 1st UP Forecast | 7.07 |
| 1st DOWN Forecast | -1.87 |
| 2nd DOWN Forecast | -5 |
| 3rd DOWN Forecast | -8.13 |
| 4th DOWN Forecast | -13.2 |
SHL Telemedicine Ltd ( SW Switzerland Symbol : SHLTN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SHLTN Business Profile
SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. The company offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center. It also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices; TeleWeight, a trans-telephonic weight monitoring device for personal use; TelePress, a remote blood pressure monitoring device for personal use; TeleBreather, a remote electronic handheld device to test the working of lungs; and TelePulse Oximeter, an electronic handheld diagnostic device to measure the saturation level of oxygen in blood, as well as pulse rate. The company offers its telemedicine services and devices to subscribers using telephonic and internet communication technology. It serves patients, health insurance companies, hospitals, clinics, physicians, and other health care providers. The company has a collaboration agreement with Mayo Clinic to evaluate the incidence of emergency department visits, re-hospitalizations, and major adverse cardiovascular events over a period of 90 days after first hospitalization for a heart attack for patients using SmartHeart FDA approved 12 lead ECG; and collaboration agreement with the Hebrew University of Jerusalem and the Hadassah Medical Center to develop an artificial intelligence tool for predicting future life-threatening cardiac events based on 12 Lead ECG monitoring. SHL Telemedicine Ltd. was founded in 1987 and is headquartered in Tel Aviv, Israel. Address: Ashdar Building, Tel Aviv, Israel, 67891
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service